Subscribe free

Intestine and Lower Gastrointestinal Tract ·

Preoperative Exclusive Enteral Nutrition Reduces Infection Risk in Crohn’s Disease Patients Undergoing Intestinal Surgery

Preoperative exclusive enteral nutrition (EEN) significantly decreases the risk of skin and soft tissue infections and intra-abdominal septic complications in Crohn’s disease (CD) patients undergoing intestinal surgery, according to a meta-analysis of 14 nonrandomized cohort studies. The relative risk of intra-abdominal septic complications was reduced by 2.1-fold, and the risk of skin and soft tissue infection decreased by 1.6-fold in patients receiving EEN. No significant differences were found in surgical duration, bowel resection length, or blood loss. These findings suggest that preoperative nutritional support with EEN should be considered for CD patients requiring bowel resection surgery.

Journal Article by Krasnovsky L, Weber AT (…) Lewis JD et 2 al. in Inflamm Bowel Dis

© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

read the whole article in Inflamm Bowel Dis

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

Br J Surg4 Nov 2026

Robot matches laparoscopy for rectal cancer survival

Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.

All papers in Intestine and Lower Gastrointestinal Tract →